statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NeuBase Therapeutics announces receipt of Nasdaq notice

NeuBase Therapeutics announces receipt of Nasdaq notice...

NeuBase Therapeutics Announces Receipt of Notice from Nasdaq

PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ( NeuBase or the Company ) today reported that it received a notice (the Notice) on April 4, 2024 from...

NeuBase Therapeutics (NASDAQ:NBSE) and Lisata Therapeutics (NASDAQ:LSTA) Critical Comparison

Lisata Therapeutics (NASDAQ:LSTA  Get Free Report) and NeuBase Therapeutics (NASDAQ:NBSE  Get Free Report) are both small-cap medical companies, but which is the superior stock? We will...

12 titoli sanitari in movimento, after-market del 23/02/2024

Titoli in rialzo
Il titolo NeuBase Therapeutics (NASDAQ:NBSE) ha osservato un incremento del 30,52% a 0,98 dollari durante la sessione after-market di venerd .
Le azioni di Ocean Biomedical...

12 acciones de salud en movimiento en la subasta de cierre del 23/02/2024

Acciones al alza
NeuBase Therapeutics (NASDAQ:NBSE) avanzaron un 31,85% para establecerse en los 0,99 d lares durante la sesi n del after-market del viernes.
Ocean Biomedical (NASDAQ:OCEA) subieron...

NeuBase Therapeutics (NASDAQ:NBSE)  Shares Down 3.3%

NeuBase Therapeutics, Inc. (NASDAQ:NBSE  Get Free Report) shares dropped 3.3% on Thursday . The stock traded as low as $0.68 and last traded at $0.69. Approximately 37,086 shares changed hands...

NeuBase Therapeutics (NASDAQ:NBSE)  Shares Down 2.7%

Shares of NeuBase Therapeutics, Inc. (NASDAQ:NBSE  Get Free Report) traded down 2.7% during trading on Tuesday . The company traded as low as $0.70 and last traded at $0.72. 84,031 shares...

NeuBase Therapeutics is a pre-clinical stage biopharmaceutical company that develops gene silencing therapies with its synthetic antisense oligonucleotides. It also provides a platform that focuses on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy, and Familial Parkinson's Disease, among others.

Volume	97,744.00
52-Wk High	$3.16
52-Wk Low	$0.36

NBSE NeuBase Therapeutics Inc

About

Feed

News

Fundamentals